NurExone advances optic nerve program toward larger-animal study
NurExone says preclinical results at Sheba Medical Center showed retinal recovery using its exosome-based lead candidate NurExone, and the program is moving toward larger-animal study.
Story updates
08:07:14 PM UTC
SquawkNews
NurExone reported preclinical optic nerve injury results showing ERG improvements with ExoPTEN vs control and plans to advance to a larger-animal (rabbit) study, subject to protocol, funding and approvals.Material DetailsContext by AI AnalystThis is early-stage but adds to prior preclinical signals…